Home Conference News Editor Reflections: Claudia Willmes of Cell Press on RNA Editing eSymposia

Editor Reflections: Claudia Willmes of Cell Press on RNA Editing eSymposia

-

Keystone Symposia meetings, whether in-person or virtual, are important venues to connect editors with scientists to facilitate publication for both parties.  Here we connect with Dr. Claudia Willmes, Editor for Trends in Molecular Medicine at Cell Press, about her participation in the RNA Editing & Modifications” eSymposia, the state of the field, and new initiatives to highlight diversity at her journal.

“RNA Editing & Modifications” eSymposia content is now available On-Demand!

          • Watch speaker presentations and career roundtable
          • Explore forums, job board and more!



Editor Reflections

Why are you attending this conference? What do you hope to get out of it?

Dr. Willmes: I am excited about this fast-moving and quickly growing field of RNA modification and RNA editing. My goal is to spot trends that are still in the early investigative stages and get a glimpse on the translational studies at the meeting. I am also hoping to learn about the needs and aspirations of the community and strengthen the bridge between basic science researchers and clinical scientists.

 

How does this conference fit into the research landscape of the field?

Dr. Willmes: Articles in Trends in Molecular Medicine are located at the interface of Biology, Pathology and Therapeutics; thus this conference program perfectly aligns with the journals scope.

 

What are the exciting things happening at your journal right now? 

Dr. Willmes: As the saying goes “A figure is worth a thousand words.” Trends in Molecular Medicine recently introduced a new graphical article type the “Strategy of the month” that boils down the main features of a new therapeutic strategy or new aspects of an established therapy in a visual way providing essential information for bench researchers and clinicians alike.

To highlight the diversity of scientists and increase visibility for our authors that come from underrepresented/disadvantaged groups, Trends in Molecular Medicine is starting an article series that offers each author team one slot to portraits an author’s journey in science. With these author portraits I hope to inspire and motivate other scientists to pursue research and join the melting pot discipline molecular medicine.

 

What’s your top tip for a scientist looking to publish in your journal?

Dr. Willmes: Propose your idea to Trends in Molecular Medicine—I love to hear what you are excited about and you don’t have anything to lose. Even if we might not proceed with your proposal, it will certainly make me aware of the topic and I can keep it in mind for the future. We offer different article types from short communications about discussions in the community and upcoming trends, to opinions and full reviews of established topics. Make sure what your main points are and choose the article type that fits best with your idea. When reaching out to me, please briefly explain your expertise in proposed topic, why your topic is important and why now, and how this is different from other recently published articles.

 

What’s the best way for attendees to get in touch with you after the meeting?

Dr. Willmes: Feel free to reach out to me via email at cwillmes@cell.com to propose an article, get feedback on an article idea, or to simply learn more about the journal or publishing with Cell Press.

 

Shannon Weiman
Shannon Weiman
Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.
 

Keystone Symposia on Molecular and Cellular Biology is a 501(c)(3) nonprofit organization with a 47-year history of convening open, peer-reviewed conferences that connect the scientific community and accelerate life science discovery.